Commentary

It’s Time to Squarely Discuss Proposed Penalty through Drug Price Cuts

Lexicon

3 price-band (bracket) grouping rule:
3価格帯ルール

The Column

Don’t Accept the Offer

Archives

Chuikyo OKs Basic Plan for Pilot-Based HTA Scheme; Sovaldi, Opdivo Emerge as Likely Candidates(Feb.12)
Chuikyo Submits Recommendation for FY2016 Reimbursement Policy Reform, New Generic Incentive for Clinics Already Questioned(Feb.12)
Alecensa Japan PIII Trial Halted Early for Benefit(Feb.12)
Working Group Debate Kicks Off toward Realizing New Ryukaikon Proposal(Feb.12)
Lilly’s Japan Sales Slip 2% to US$1.9 Billion in 2015(Feb.12)

Most Read

1.
BMS, Pfizer to Codevelop Factor Xa Antid...
2.
Editor’s Pick: Five Healthcare Policy Ne...
3.
Mitsubishi Tanabe to Establish Stand-Alo...
4.
FDA Panel Backs Effectiveness of Brintel...
5.
Takeda Expands ADC Collaboration with US...

News Calendar